Patents by Inventor Albert Johannes Joseph Van Ooyen

Albert Johannes Joseph Van Ooyen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7033627
    Abstract: A method of catalyzing in vitro reactions using seeds containing enhanced amounts of enzymes is disclosed. The method involves adding transgenic, non-wild type seeds, preferably in a ground form, to a reaction mixture, especially a bakery process and allowing the enzymes in the seeds to increase the rate of reaction. By directly adding the seeds to the reaction mixture the method provides a solution to the expensive and problematic process of extracting and purifying the enzyme. Methods of treatment are also provided whereby a subject lacking a sufficient supply of an enzyme is administered the enzyme in the form of seeds containing enhanced amounts of the enzyme.
    Type: Grant
    Filed: February 2, 1998
    Date of Patent: April 25, 2006
    Assignees: Syngenta Mogen B.V., Gist-Brocades N.V.
    Inventors: Albert Johannes Joseph Van Ooyen, Krijn Rietveld, Wilhelmus Johannes Quax, Jan Pen, Andreas Hoekema, Peter Christiaan Sijmons, Teunis Cornelis Verwoerd
  • Patent number: 6602682
    Abstract: Kluyveromyces hosts and DNA expression cassettes for use in Kluyveromyces are provided for transcription of endogenous and/or exogenous DNA, and production of peptides, for enhancing production of an endogenous product, or producing an exogenous product. The Kluyveromyces hosts find particular use for secretion of a desired peptide product, where signal sequences may be native to the peptide or provided from endogenous or exogenous signal sequences, including synthetic sequences, functional in Kluyveromyces. A transformation procedure is provided for efficiently transforming Kluyveromyces.
    Type: Grant
    Filed: May 29, 1991
    Date of Patent: August 5, 2003
    Assignee: DSM N.V.
    Inventors: Johan Abel Van Den Berg, Albert Johannes Joseph Van Ooyen, Krijn Rietveld, Cornelis P. Hollenberg, Sunil Das, Albert De Leeuw
  • Patent number: 6346513
    Abstract: Novel polypeptides having Factor VIII activity are provided as well as compositions and methods for their preparation. The polypeptides comprise derivatives and fragments of Factor VIII and have sequences substantially similar to portions of naturally occuring Factor VIII. The polypeptides find use in treatment of Hemophilia A.
    Type: Grant
    Filed: April 3, 1995
    Date of Patent: February 12, 2002
    Assignee: Baxter Trading GmbH
    Inventors: Albert Johannes Joseph Van Ooyen, Hans Pannekoek, Martinus Philippus Verbeet, Robert Willem Van Leen
  • Patent number: 6316226
    Abstract: Novel polypeptides having Factor VIII activity are provided as well as compositions and methods for their preparation. The polypeptides comprise derivatives and fragments of Factor VIII and have sequences substantially similar to portions of naturally occuring Pactor VIII. The polypeptides find use in treatment of Hemophilia A.
    Type: Grant
    Filed: April 3, 1995
    Date of Patent: November 13, 2001
    Assignee: Baxter Trading GmbH
    Inventors: Albert Johannes Joseph Van Ooyen, Hans Pannekoek, Martinus Philippus Verbeet, Robert Willem Van Leen
  • Patent number: 5840528
    Abstract: The present invention discloses a transformed Phaffia strain. Also disclosed are specific vectors for transforming Phaffia, preferably such vectors contain expression regulating sequences obtained from Phaffia. The present invention also discloses the use of certain marker genes in Phaffia. The invention further discloses a method for transforming Phaffia.
    Type: Grant
    Filed: June 23, 1995
    Date of Patent: November 24, 1998
    Assignee: Gist-Brocades, N.V.
    Inventor: Albert Johannes Joseph Van Ooyen
  • Patent number: 5830737
    Abstract: The exo-polygalacturonase gene from Aspergillus is identified, and the enzyme encoded thereby is expressed. Specifically, the exo-polygalacturonase gene from Aspergillus tubingensis is is cloned and expressed, and DNA sequences from other Aspergillus strains that specifically hybridize therewith are identified. Novel expression vectors that comprise an exo-polygalacturonase encoding sequence, and host cells transformed therewith, are also provided. The invention further relates to the production of recombinant exo-polygalacturonase, and to the use of this protein.
    Type: Grant
    Filed: January 24, 1997
    Date of Patent: November 3, 1998
    Assignee: Gist-Brocades, N.V.
    Inventors: Margo Anne-Rose Kusters-Van Someren, Yvonne Muller, Hermanus Cornelis Maria Kester, Jacob Visser, Albert Johannes Joseph Van Ooyen, Claus Rolin
  • Patent number: 5705375
    Abstract: The present invention provides plants with a modified taste, solids content and/or texture. The invention also provides methods of obtaining such plants via transformation with DNA constructs containing genes encoding enzymes capable of degrading plant polysaccharides and optionally additional genes encoding enzymes which are capable of further modifying the degradation products resulting from the first degradation step.
    Type: Grant
    Filed: June 3, 1994
    Date of Patent: January 6, 1998
    Assignee: MOGEN International, N.V.
    Inventors: Albert Johannes Joseph Van Ooyen, Krijn Rietveld, Wilhelmus Johannes Quax, Petrus Josephus Maria Van Den Elzen, Jan Pen, Andreas Hoekema, Peter Christiaan Sijmons